The 17 kDa band identified by multiple anti-aquaporin 2 antisera in rat kidney medulla is a histone  by Jo, Inho et al.
 .Biochimica et Biophysica Acta 1324 1997 91–101
The 17 kDa band identified by multiple anti-aquaporin 2 antisera in rat
kidney medulla is a histone
Inho Jo a, Soren Nielsen b, H. William Harris a,)
a Di˝ision of Nephrology, Room 1260, Enders Building, Children’s Hospital, Har˝ard Medical School, 300 Longwood A˝enue, Boston,
MA 02115, USA
b Department of Cell Biology, Uni˝ersity of Aarhus, Aarhus, Denmark
Received 6 March 1996; revised 4 September 1996; accepted 1 October 1996
Abstract
The osmotic water permeability of epithelial cells of the inner medullary collecting duct of the kidney is regulated by
 .antidiuretic hormone ADH . ADH causes the insertion and removal of cytoplasmic vesicles containing the aquaporin
 .AQP-2 water channel protein which is recognized by multiple rabbit antipeptide antisera raised against amino acid
sequences comprising its cytoplasmic carboxyl terminal. Immunoblots of rat kidney membrane fractions as well as human
urine have all shown that AQP-2 is expressed exclusively by collecting duct cells and have identified a 29 kDa band
 . corresponding to the nonglycosylated AQP-2 protein , a broad 35–45 kDa band corresponding to the mature glycosylated
.form of AQP-2 protein and an additional immunoreactive 17 kDa band of unknown origin. We now report that the 17 kDa
band identified by these anti-AQP-2 antisera is not an AQP-2 component but rather a denatured histone protein type H2A1.
This binding of anti-AQP-2 antisera to denatured H2A1 present in protein samples derived from both kidney inner medulla
and human urine is blocked specifically by preincubation of immunoblots with solutions containing the acidic protein
gelatin.
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1. Introduction
 .Antidiuretic hormone ADH regulates the apical
membrane osmotic water permeability in epithelial
cells of the collecting duct by the insertion and
removal of cytoplasmic vesicles containing water
w xchannels 1–3 . A large amount of data including
Abbreviations: ADH, antidiuretic hormone; AQP, aquaporin;
SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis; BSA, bovine serum albumin; PVDF, polyvinylidene
difluoride; TFA, trifluoroacetic acid; PKA, cAMP-dependent pro-
tein kinase A; PBS, phosphate-buffered saline
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Northern- and Western-blotting, in situ hybridization,
immunocytochemistry and oocyte expression studies
w x4–13 , as well as patients with nephrogenic diabetes
 .insipidus possessing mutant aquaporin 2 AQP-2
w xproteins 14 , have identified the AQP-2 protein as
the ADH-elicited water channel. AQP-2 is a member
of the AQP family of water channel proteins that is
distinguished by several common structural features
w x15 . A central feature of the AQP proteins is the
presence of six transmembrane domains in combina-
tion with an extracellular and intracellular loop that is
postulated to form a water-selective pore spanning
w xthe lipid bilayer of the cell membranes 15,16 . All
AQPs including AQP-2 possess a high degree of
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amino acid identity in these channel-forming domains
whereas amino acids comprising the cytoplasmic car-
boxyl terminal domains of various AQPs are highly
divergent. Antipeptide antisera raised against the
amino acid sequences of AQP carboxyl terminal do-
mains have been used in both immunoblotting and
immunolocalization experiments as reagents to distin-
guish individual members of the AQP family.
Multiple anti-AQP-2 antisera raised by several lab-
oratories have uniformly identified a 29 kDa band
corresponding to the nonglycosylated AQP-2 pro-
. tein and a broad 35–45 kDa band corresponding to
.the mature glycosylated form of AQP-2 protein on
immunoblots of membranes prepared from kidney
w xmedulla and papilla 6–13 . However, reports from
wanalyses of both kidney cell membrane fractions 6–
x w x12 and urinary protein fractions 8,13 from both rats
w x w x6–12 and humans 8,13 have identified an addi-
tional immunoreactive 17 kDa band. Although its
actual origin and structure are unknown, this 17 kDa
band has been postulated to be a proteolytic fragment
w xof AQP-2 6,8,12 that may be excreted in the urine
w x8 . We now report that the 17 kDa band identified by
multiple anti-AQP-2 antisera is not a component of
the AQP-2 protein but rather denatured histone pro-
tein type H2A1, abundantly present in the kidney
inner medulla and papilla where it is recognized
specifically by some but not all anti-AQP-2 antisera.
While anti-AQP-2 antisera exhibit significant binding
to denatured H2A1 histone protein on immunoblots,
these antisera are not likely to bind to histone H2A1
when it is complexed with DNA in the inner medulla
w xand papilla 5 . This spurious binding of anti-AQP-2
antisera to denatured H2A1 is significantly elimi-
nated by preincubation of immunoblots with blocking
solutions containing the acidic protein gelatin.
2. Materials and methods
2.1. Preparation of membrane fractions from rat
brain, kidney inner medulla and papilla as well as
human urine
Crude membrane fractions were isolated from
freshly excised various regions of kidney cortex,
.outer medulla, and inner medulla and papilla or
brains of female Sprague-Dawley rats Charles River
.Laboratories, Billerica, MA as described previously
w x 5,6,11 . Briefly, crude homogenates in Buffer A 300
 .mM mannitol, 12 mM Hepes pH 7.6 containing 0.1
mM phenylmethylsulfonyl fluoride and 5 mgrml leu-
 ..peptin Sigma Chem. Co., St. Louis, MO were
centrifuged at 325=g for 10 min to pellet unbroken
cells and nuclei. Crude membranes were then col-
lected by centrifugation of the resulting supernatant
at 100 000=g for 1 h. These membranes were then
solubilized directly in SDS-PAGE solubilization
buffer and stored at y808C prior to use.
To prepare subcellular fractions of rat inner
medulla and papilla, crude homogenates were sub-
jected to sequential centrifugation steps and the re-
sulting pellet from each step solubilized directly in
 .SDS-PAGE solubilization buffer. These included: 1
 .  .325=g for 10 min unbroken cells and nuclei ; 2
2500=g for 20 min large plasma membrane sheets
.  .and highly dense organelles ; 3 48 000=g for 30
 .  .min mitochondria and assorted organelles ; and 4
200 000=g for 60 min low density microsomal
.  .fraction and 5 cytosol.
A crude membrane fraction from human urine was
w xprepared as described 13 with modification. Briefly,
random urine samples were obtained from healthy
volunteers after an interval of 12 h of water depriva-
tion. The urine was first centrifuged at 325=g for
10 min to remove larger debris. A crude urinary
membrane fraction was then collected by centrifuga-
tion of the resulting supernatant at 100 000=g for 1
h and corresponding pellet solubilized directly in
SDS-PAGE solubilization buffer that was stored at
y808C prior to use.
2.2. Immunoblotting of kidney and brain membrane
proteins
Protein samples containing either crude kidney
membranes, brain membranes or purified histone
 .H2A1 Sigma were fractionated by SDS-PAGE as
w xdescribed previously 5,6,11 then subjected to West-
ern blot transfer of proteins to nitrocellulose filters
 .Schleicher and Schuell, Keene, NH in 192 mM
 .glycine, 25 mM Tris pH 8.3 at 110 V for 2 h. In
selected experiments, histone H2A1 was applied di-
rectly to the nitrocellulose membrane by dot blotting.
Membranes were then blocked with either 2% bovine
 .  .serum albumin BSA Sigma at 258C for 1 h or 3%
 .gelatin J.T. Baker, Phillipsburg, NJ at 378C for 1 h
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 . in phosphate-buffered saline PBS 100 mM NaCl,
 ..50 mM sodium phosphate pH 7.4 and 0.3%
 . Tween-20 Biorad Lab., Richmond, CA PBS-
.Tween .
After rinsing in PBS-Tween, membranes were in-
cubated at 258C for 1 h with 1:2000 dilution of rabbit
antisera raised against various peptides containing
sequences corresponding to those reported for the
carboxyl terminal domain of AQP-2. After rinsing in
PBS-Tween, bound anti-AQP-2 antibody was de-
tected by affinity purified anti-rabbit antisera and
 . enhanced chemiluminescence ECL Amersham Life
.Sci., Arlington Heights, IL as described previously
w x6,11 . Immunoreactivity was quantified by using a
Zeineh Soft Laser densitometer as detailed previously
w x17 . Various rabbit anti-AQP-2 antisera tested in-
 .cluded those raised against AQP-2 amino acids: 1
a257–271 Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-
. w xPro-Arg-Gly-Cys-Lys-Ala in our laboratory 5,6,11 ,
 .or 2 antisera raised to the identical amino acid
sequence kindly provided by C. Van Os, Nijmegen,
. . The Netherlands , 3 a250–271 Glu-Val-Arg-Arg-
Arg-Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-
. Pro-Arg-Gly-Ser-Lys-Ala kindly provided by M.
. w xKnepper, LKEM, NIH, Bethesda, MD 5,9,12 , or
 . w x 4 a256–271 18 kindly provided by D. Brown,
.Boston, MA . As additional controls, other rabbit
antisera were also tested including anti-G andia 1 – 2
 .G UBI, Lake Placid, NY .ia 3
2.3. Purification of 17 kDa protein recognized by
anti-AQP-2 antiserum
Kidney membranes suspended in Buffer A were
solubilized by addition of Triton X-100 BioRad
.Lab., Richmond, CA to a final concentration of
1.5%. After incubation at 48C for 1 h, the resulting
Triton X-100-insoluble protein complex was pelleted
 .by centrifugation 16 000=g for 20 min , solubi-
 .lized in 100% trifluoroacetic acid TFA and sub-
jected to SDS-PAGE after neutralization of TFA with
solid Tris. After transfer of TFA-solubilized proteins
 . to polyvinylidene difluoride PVDF membranes Im-
.mobilon-P, Millipore Corp., Bedford, MA in 10 mM
 .  .CAPS buffer pH 11.0 Sigma containing 20%
methanol and staining with 0.1% amido black, the 17
kDa band was subjected to digestion with trypsin and
microsequence analyses by the Rockefeller Univer-
sity Biopolymer Facility using methodology de-
w xscribed previously 19 . The identity of the resulting
protein sequence was obtained upon search of the
GENBANK protein database National Library of
.Medicine, Bethesda, MD . A total of three partial
sequences were obtained all of which were exact
matches to histone H2A1.
2.4. Phosphorylation and immunoprecipitation of
AQP-2
Rat kidney inner medullary and papillary endo-
somes containing abundant AQP-2 protein were puri-
w xfied as described previously 11 and incubated at
378C in Buffer B 300 mM mannitol, 100 mM KCl, 5
 ..mM MgSO , 5 mM Hepes pH 7.6 containing 5%4
 .  .vrv glycerol and 0.05% vrv 2-mercaptoethanol
w 32 x  . with 100 mM g- P ATP 10 Cirmmol New Eng-
.land Nuclear, Boston, MA and purified catalytic
 .subunit of cAMP-dependent protein kinase A PKA
 .  .20 Urml Sigma for 3 min to phosphorylate AQP-
2. Labeled endosomes were then solubilized by addi-
tion of Triton X-100 to a final concentration of 1.5%
and incubated at 48C for 1 h. Triton X-100-insoluble
material was removed by centrifugation 16 000=g
.for 20 min and the Triton X-100-soluble supernatant
subjected to immunoprecipitation using protein A-
purified anti-AQP-2 antiserum linked to Sepharose
w x4B as described previously 20 . After extensive
washing in PBS, bound AQP-2 protein was solubi-
lized by SDS-PAGE solubilization buffer and sub-
jected to SDS-PAGE and autoradiography as de-
w xscribed previously 20 .
2.5. Assay to detect endogenous proteolysis of AQP-2
protein
Kidney inner medullary and papillary membrane
fraction containing abundant AQP-2 was prepared
after centrifugation at 48 000=g for 30 min during
sequential centrifugation steps as described above,ex-
cept that no protease inhibitors were included in any
of the solutions used for suspension of membrane
fractions. This membrane fraction was divided into
two equal aliquots where one was incubated at 378C
for 1 h while the other was incubated on ice. The
incubation was stopped by the addition of SDS-PAGE
solubilizing buffer and assessed by immunoblotting
using anti-AQP-2 antiserum as described above.
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3. Results
3.1. Anti-AQP-2 antiserum specifically recognizes a
17 kDa band in addition to bands of 29 kDa and
35–45 kDa in immunoblots of proteins from rat
kidney inner medulla and papilla
w x w xWe 5,6,11,12 and others 4,7,10,21 have previ-
ously employed rabbit antisera raised against the
sequence Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-
Arg-Gly-Ser-Lys-Ala corresponding to amino acids
a257–271 in the carboxyl terminal domain of rat
w xAQP-2 4 in immunoblotting, immunoprecipitation
and immunolocalization experiments in rat kidney
inner medulla and papilla. This antiserum identifies
three major immunoreactive bands of 17 kDa, 29 kDa
and a broad band between 35 and 45 kDa in crude
membrane fractions prepared from the medulla and
 .papilla of rat kidney Fig. 1A . The 17 kDa band is
most prominently displayed in lanes from the inner
 .medulla and papilla Fig. 1A, lane 8 and to a lesser
extent in membrane fractions prepared from other
 .regions of the kidney Fig. 1A, lanes 6 and 7 . As
shown in lanes 1–5, the 17 kDa band is not visual-
ized in various other rat tissue membranes under
these conditions.
The presence of this 17 kDa band is not the result
of nonspecific binding of rabbit antiserum to proteins
of the kidney inner medulla and papilla since im-
munoblots using preimmune antiserum do not display
 .binding in this region of the gel Fig. 1B . As addi-
tional controls, we tested other commercial rabbit
 antisera anti-G and G UBI, Lake Placid,ia 1 – 2 i a 3
..NY under identical conditions and observed no 17
 .kDa band data not shown . Furthermore, we have
w xdemonstrated previously 6 that a pattern of im-
munoreactive bands identical to that shown in Fig.
1A, lane 8 is observed using affinity purified antisera
and that the appearance of all three bands is ablated
by preincubation of anti-AQP-2 antisera with excess
peptide.
3.2. Experiments in˝estigating the subcellular distri-
bution, enzyme digestion and immunoprecipitations
using anti-AQP-2 antiserum suggest the 17 kDa band
is not a proteolytic fragment of AQP-2
If the 17 kDa immunoreactive band is a compo-
nent of the AQP-2 protein, then all AQP-2 bands
Fig. 1. Immunoblotting analysis of various rat tissues with anti-
 .AQP-2 antisera. A Immunoblots containing 40 mgrlane of
protein from crude membranes prepared from homogenates of rat
 .  .  .  .brain lane 1 , heart lane 2 , liver lane 3 , lung lane 4 spleen
 .  .  .lane 5 , kidney cortex lane 6 , outer medulla lane 7 and inner
 .medulla and papilla lane 8 were blocked using 2% BSA, probed
with 1:2000 dilution of rabbit anti-AQP-2 antiserum then devel-
oped for the presence of bound antibody using chemilumines-
 .cence see Section 2 . Arrows and bracket on the right margin of
the blot denote the specific AQP-2 bands of 17 kDa, 29 kDa and
 .35–45 kDa present in kidney lanes 6–8 but not other tissues
 .lanes 1–5 . These data from a single experiment are representa-
 .tive of a total of three experiments. B Immunoblot strips
containing 40 mgrlane of rat kidney inner medulla and papilla
membrane protein were probed as described in A with either
 .  .preimmune lane 1 or immune lane 2 anti-AQP-2 antiserum.
Specific AQP-2 bands of 17 kDa, 29 kDa and 35–45 kDa are
present in lane 2 but not lane 1. These data from a single
experiment are representative of a total of five experiments.
Small arrowheads denote the relative migration of proteins of
 y3.known molecular mass P10 .
recognized by anti-AQP-2 antiserum should be en-
riched in membrane fractions prepared from ho-
mogenates of rat kidney inner medulla and papilla.
However, as shown in Fig. 2 the 17 kDa band is
prominent only in subcellular fractions produced by
centrifugation of homogenates at low centrifugal
 .forces Fig. 2, lanes 2 and 3 and not those produced
 .by high centrifugal forces Fig. 2, lanes 4 and 5 .
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Fig. 2. The 17 kDa immunoreactive band is enriched in subcellu-
lar fractions prepared by centrifugation of rat inner medulla
homogenates at low centrifugal force. Rat kidney inner medullary
 .and papillary homogenate lane 1 was subjected to sequential
centrifugation steps of increasing magnitude and the resulting
membrane pellets subjected to immunoblotting as described in
 .Fig. 1. Crude homogenate lane 1 was centrifuged sequentially
 .  .at 325= g for 10 min lane 2 , 2500= g for 20 min lane 3 ,
 . 48 000= g for 30 min lane 4 and 200000= g for 60 min lane
.  .5 . The remaining supernatant was also analyzed lane 6 . A total
of 40 mg of protein was loaded in each lane. The small rightward
pointing arrowheads denote the position of protein of known
 y3.molecular mass P10 . These data derive from a single experi-
ment representative of a total of six experiments.
While both the 29 kDa and 35–45 kDa immunoreac-
tive AQP-2 bands are observed in lanes 2–5, the 17
kDa immunoreactive band is observed only faintly
 .Fig. 2, lane 3 and is not present in membrane
 .fractions shown Fig. 2, lanes 4 and 5 . These data
show that the relative abundance of immunoreactivity
of the 17 kDa AQP-2 band can be dissociated from
that observed by the other AQP-2 bands of larger
molecular mass.
It is also possible that the 17 kDa immunoreactive
band is a proteolytic fragment of the larger 29 kDa
and 35–45 kDa AQP-2 protein generated by endoge-
nous proteases present in kidney inner medullary and
papillary membrane fractions. To determine if AQP-2
is proteolyzed during its isolation from cells, we
prepared and incubated this kidney membrane frac-
tion containing abundant AQP-2 prepared as shown
.in lane 4 of Fig. 3 at 378C for 1 h in the complete
absence of any protease inhibitors. Under these con-
ditions, we observed no 17 kDa protein production as
 .detected by anti-AQP-2 antiserum Fig. 3, lane 2 . In
addition, the immunoreactivity of both 29 kDa and
broad 35–45 kDa bands was retained completely
after the 1 h incubation at 378C as compared to
 .incubation on ice Fig. 3, lane 1 . These data suggest
Fig. 3. No 17 kDa band is produced by incubation of membrane
fractions containing AQP-2 at 378C in the absence of proteolytic
inhibitors. A kidney membrane fraction containing abundant
AQP-2 was prepared from the pellet shown in lane 4 of Fig. 2
during sequential centrifugation steps as described in Fig. 2. For
this experiment, all inhibitors of proteolytic enzymatic activity
were eliminated from all solutions. Subsequently, aliquots of this
high-speed fraction were then subjected to incubation at 378C for
 .  .1 h lane 2 or incubated on ice for 1 h lane 1 as a control.
Proteolysis of AQP-2 was assessed by Western blotting analysis
using anti-AQP-2 antiserum. Despite incubation under conditions
that may result in AQP-2 proteolysis, no 17 kDa band is recog-
 .nized after incubation at 378C for 1 h lane 2 .
that the 17 kDa band is not a proteolytic fragment of
the larger 29 kDa or 35–45 kDa bands.
As an additional control, we carried out immuno-
precipitations using anti-AQP-2 antisera after 32P-
labeling of AQP-2 in order to examine the possibility
that the 17 kDa immunoreactive band is a fragment
of the parent AQP-2 protein. Serine a256 of AQP-2
w xis phosphorylated by addition of exogenous PKA 21
and only two amino acids separate this PKA phos-
phorylation site from the amino acid sequence recog-
nized by the anti-AQP-2 antiserum. As a result, any
generation of a 17 kDa fragment of AQP-2 recog-
nized by the anti-AQP-2 antiserum would necessitate
that proteolytic cleavage of the AQP-2 protein occur
in the central portion of the full length AQP-2 se-
quence. Thus, anti-AQP-2 antiserum should immuno-
precipitate a 32P-labeled 17 kDa band of AQP-2 if
the 17 kDa protein band is actually a fragment of
AQP-2. However, as shown in Fig. 4, only the 32P-
labeled 29 kDa and 35–45 kDa bands corresponding
to full length nonglycoslylated and glycoslyated forms
of AQP-2 protein were recovered in the immunopre-
cipitate. Taken together, these data displayed in Figs.
2–4 do not support the identity of the 17 kDa im-
munoreactive band as a carboxyl terminal proteolytic
fragment of AQP-2.
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Fig. 4. No 32P-labeled 17 kDa band is recovered in immunopre-
cipitates of kidney inner medulla and papillary membranes using
anti-AQP-2 antisera. After 32P-labeling of inner medullary and
papillary membranes by addition of purified catalytic subunit of
 .  .the cAMP-dependent protein kinase A PKA see Section 2 ,
membranes were solubilized in 1.5% Triton X-100 and the Triton
X-100-insoluble portion removed by centrifugation 16000= g
.for 20 min . The resulting supernatant was subjected to immuno-
precipitation using Sepharose conjugated with anti-AQP-2 anti-
serum. After extensive washing of the Sepharose, bound protein
was eluted by addition of SDS-PAGE solubilization buffer, frac-
tionated and the SDS-PAGE gel dried and autoradiographed.
Note that only proteins of 29 kDa and 35–45 kDa are visible in
the autoradiogram shown. These data from a single experiment
are representative of group of 10 experiments.
3.3. The purified 17 kDa protein recognized by the
anti-AQP-2 antiserum is histone H2A1
As shown in Fig. 5, examination of the fate of the
17 kDa immunoreactive band after Triton X-100
solubilization reveals that greater than 98% of the
anti-AQP-2 immunoreactivity is retained in the Tri-
 .ton X-100-insoluble pellet Fig. 5, lane 3 as com-
pared to the Triton X-100 supernatant Fig. 5, lane
.2 . However in contrast to the bulk of the proteins
that comprise the Triton X-100-insoluble pellet, the
17 kDa immunoreactive protein can be solubilized by
 .subsequent addition of 100% TFA Fig. 5, lane 4 .
After SDS-PAGE fractionation, TFA-solubilized 17
kDa protein was transferred to PVDF membrane and
subjected to limited proteolytic digestion and protein
sequence analysis. A total of three partial sequences
were obtained the longest of which was a total of 14
amino acids Thr-Arg-Ile-Ile-Pro-Arg-His-Leu-Lys-
.Leu-Ala-Ile-Arg-Asn . All three sequences were iden-
w xtical to sequences in histone H2A1 22 with the 14
amino acid sequence corresponding to a79–92 of
Histone H2A1. No other matches were recovered in
searches of the Genbank protein sequence data base.
Fig. 5. The 17 kDa immunoreactive protein is recovered in Triton
 .X-100-insoluble and trifluoroacetic acid TFA -soluble fractions.
Membranes from the inner medulla and papilla were dissolved in
1.5% Triton X-100 as described in Fig. 4. Identical aliquots of 50
 .mg of protein from starting material lane 1 , Triton X-100-solu-
 .  .ble lane 2 and Triton X-100-insoluble lane 3 fractions as well
 .  .as TFA-soluble lane 4 and TFA-insoluble lane 5 fractions of
the Triton X-100-insoluble fraction were subjected to immuno-
blotting analysis using anti-AQP-2 antisera as described in Fig. 1.
Note that greater than 98% of the 17 kDa immunoreactivity is
recovered in the Triton X-100-insoluble fraction that is subse-
quently soluble in TFA.
These data are consistent with enrichment of the 17
kDa band in subcellular fractions of rat kidney
medulla and papilla homogenates containing nuclei
 .Fig. 2, lane 2 as compared to other membrane
 .fractions Fig. 2, lanes 3–5 . Furthermore, the acid
solubility of the 17 kDa protein recognized by anti-
AQP-2 antiserum corresponds to the well known
solubility of the histone H2A1 protein in acid solu-
w xtions 23 .
3.4. Histone H2A1 is recognized by anti-AQP-2 anti-
sera but antibody binding to H2A1 may be eliminated
by preincubation with gelatin
To obtain confirmatory data that the 17 kDa pro-
tein recognized by anti-AQP-2 antiserum is indeed
histone H2A1, immunoblots containing purified
H2A1 were probed with anti-AQP-2 antiserum. As
shown in Fig. 6, anti-AQP-2 antiserum recognizes a
17 kDa band in lanes containing purified histone
H2A1 that co-electrophoreses with the 17 kDa pre-
sent in crude membrane fractions from rat kidney
inner medulla and papilla. However, the apparent
degree of anti-AQP-2 immunoreactivity displayed by
purified H2A1 is surprisingly low after SDS-PAGE
 .and Western blot transfer Fig. 6, lanes 2–6 . These
data result from the poor transfer of histone H2A1
from the gel to the nitrocellulose membrane under
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Fig. 6. Anti-AQP-2 antiserum recognizes purified histone H2A1.
Individual lanes loaded with either 40 mg of inner medullary and
 .  .papillary membrane proteins lane 1 or 0.5 mg lane 2 , 1 mg
 .  .  .  .lane 3 , 2 mg lane 4 , 4 mg lane 5 and 8 mg lane 6 of
histone H2A1 were subjected to SDS-PAGE and Western blot
transfer prior to immunoblotting analysis as described in Fig. 1.
Alternatively, lane 7 shows the results of direct application of 0.5
 .  .  .mg a , 1 mg b and 2 mg c of H2A1 to the nitrocellulose filter
followed by immunoblotting analysis in a fashion identical to
lanes 1–6. Note that the anti-AQP-2 antiserum recognizes a 17
kDa band in both kidney membranes as well as histone H2A1.
these Western blotting conditions, since application
of purified H2A1 protein to the nitrocellulose filter
via dot blotting yields anti-AQP-2 immunoreactivity
using as little as 500 ng of histone H2A1 Fig. 6, lane
.7 .
To obtain additional data linking the 17 kDa im-
munoreactive protein of rat kidney inner medulla and
papilla to the properties of histone H2A1, im-
munoblots were blocked by preincubation with either
2% BSA or 3% gelatin. In contrast to BSA, gelatin is
an acidic protein that readily binds to basic histones
w x23 . As shown in Fig. 7, preincubation of lanes with
 .3% gelatin Fig. 7, lanes 2, 4 and 6 as compared to
 .2% BSA Fig. 7, lanes 1, 3 and 5 ablated the binding
of anti-AQP-2 antisera to the 17 kDa band present in
 .both kidney membranes Fig. 7, lanes 1 and 2 as
 .well as purified H2A1 histone Fig. 7, lanes 3–6 .
Under these conditions, no significant alteration in
the immunoreactivity of the 29 kDa or 35–45 kDa
 .AQP-2 were observed Fig. 7, lanes 1 and 2 . These
data suggest that the H2A1 epitope recognized by
anti-AQP-2 is masked by the binding of gelatin to the
denatured histone protein.
To demonstrate that histone H2A1 possesses actual
apparent crossreactivity with denatured AQP-2 pro-
Fig. 7. Preincubation of immunoblots with gelatin ablates AQP-2
antisera reactivity to both the 17 kDa immunoreactive band as
well as histone H2A1. Samples containing either 40 mg of kidney
 .  .membranes lanes 1 and 2 or purified histone H2A1 lanes 3–6
were either transferred or applied to a nitrocellulose filter in a
fashion identical to that described in Fig. 6. Portions of the filter
 .were preincubated with either 2% BSA lanes 1, 3 and 5 or 3%
 .gelatin lanes 2, 4 and 6 , then immunoblotted using anti-AQP-2
antiserum as described in Fig. 1. Note that preincubation of
 . kidney membranes lane 2 as well as histone H2A1 lanes 4 and
.6 with 3% gelatin abolishes antisera binding to both the 17 kDa
band as well as H2A1 protein. In contrast, AQP-2 bands of 29
and 35–35 kDa appear unaffected. These data are derived from a
single experiment representative of a total of four experiments.
Fig. 8. Preabsorption of anti-AQP-2 antiserum with histone H2A1
reduces the AQP-2 immunoreactivity and eliminates the appear-
ance of 17 kDa band in blots of inner medulla membranes
blocked with 2% BSA. Identical quantities of anti-AQP-2 anti-
serum were preabsorbed with Sepharose cross-linked with either
 .  .BSA lane 1 or H2A1 lane 2 . These were then used to
immunoblot 40 mgrlane of rat kidney inner medullary and
 .papillary membranes blocked with either 3% gelatin A or 2%
 .BSA B as described in Fig. 7 and Fig. 1, respectively. As
shown in A, preabsorption of anti-AQP-2 antiserum with H2A1
 .  .lane 2 reduced its reactivity by 71"17% ns5 as compared
 .to control lane 1 . Panel B demonstrates that preabsorption of
anti-AQP-2 antiserum with H2A1 protein eliminates the appear-
ance of the 17 kDa band when immunoblots are blocked with
 .BSA ns3 .
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tein, anti-AQP-2 antiserum was preabsorbed with
Sepharose conjugated with either BSA or H2A1 pro-
tein. The absorbed anti-AQP-2 antiserum was then
utilized to probe immunoblots of rat kidney mem-
 .branes blocked with 3% gelatin Fig. 8A . As com-
 .pared to the BSA control Fig. 8A, lane 1 , preincu-
 .bation with histone H2A1 Fig. 8A, lane 2 reduced
the immunoreactivity of anti-AQP-2 antisera to both
29 kDa and 35–45 kDa bands by 71"17% P-
.0.05, ns5 . In addition, as shown in Panel B of Fig.
8, preabsorption of anti-AQP-2 antisera with H2A1
 .  .lane 2 but not BSA lane 1 resulted in a disappear-
ance of the 17 kDa band from immunoblots of kidney
membranes blocked with 2% BSA. Taken together,
these data displayed in Figs. 6–8 suggest that histone
H2A1 shares epitopes present on denatured AQP-2
protein present in immunoblots.
3.5. Rabbit antisera from multiple laboratories raised
against carboxyl terminal sequences of AQP-2 con-
tain immunoreacti˝ity to both the 17 kDa band in rat
kidney membranes as well as purified histone H2A1
To determine whether the immunoreactivity of the
anti-AQP-2 antiserum raised in our laboratory is
unique in its recognition of the 17 kDa and histone
H2A1, we tested seven other anti-AQP-2 antisera
each raised independently in individual animals by
Fig. 9. Rabbit antisera from multiple laboratories contain immunoreactivity to both a 17 kDa band in rat kidney membranes and purified
 .  .  .histone H2A1. Nitrocellulose strips containing either 40 mgs of inner medullary and papillary membranes lanes 1 and 2 or 0.5 a , 1 b
 .  .  .  .or 2 c mg of histone H2A1 lanes 3 and 4 were blocked with either 2% BSA lanes 1 and 3 or 3% gelatin lanes 2 and 4 , then
 .  .incubated with individual lots of rabbit antiserum raised against various carboxyl terminal AQP-2 sequences panels A–F see Section 2 .
 . A, B Antiserum a1 and a2 raised to 22mer peptide AQP-2 amino acid a250–271 in separate rabbits provided by M. Knepper,
.  .LKEM, NIH, Bethesda, MD ; C–F Antisera a3–6 all raised to 15mer peptide AQP-2 amino acid a257–271 in separate rabbits
 .provided by our laboratory or C. Van Os, Nijmegen, The Netherlands . Note that all six antisera identify a 17 kDa immunoreactive band
in kidney membranes as well as histone H2A1 when strips are blocked with 2% BSA. In contrast, blocking with 3% gelatin ablates or
 .greatly diminishes antisera reactivity to 17 kDa band and H2A1. G Nitrocellulose strips prepared as described in panel A were
 . w ximmunoblotted in a paired experiment with either anti-AQP-2 antiserum shown in Fig. 1, lane 1 or another anti-AQP-2 antiserum 18
 .provided by D. Brown Boston, MA lane 2 after blocking strips in 2% BSA. Note that in contrast to the other seven anti-AQP-2 antisera
tested, this anti-AQP-2 antiserum does not exhibit specific reactivity to the 17 kDa band. This is a single experiment representative of a
total of four.
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our own and other laboratories. As shown in Fig.
9A–G, six of the seven exhibited identical character-
istics to that displayed in Fig. 7 using antiserum
 .raised by our laboratory, while one panel G exhib-
ited no reactivity toward proteins present in the 17
kDa region of kidney membrane immunoblots. All
six anti-AQP-2 antisera recognized a 17 kDa band in
 .rat kidney membranes Fig. 9, lane 1 and displayed
 .immunoreactivity to purified histone lane 3 that
were both ablated by preincubation with 3% gelatin
 .Fig. 9, lanes 2 and 4 . These data demonstrate that
recognition of a histone H2A1 of apparent molecular
mass of 17 kDa present in either rat kidney inner
medullary and papillary membrane fractions or puri-
fied form is not limited to a single rabbit anti-AQP-2
antiserum. Instead, a total of six antisera raised inde-
pendently to peptides containing AQP-2 carboxyl
terminal sequences all exhibit identical properties
including recognition of a 17 kDa band while another
displays no such reactivity.
Immunoblotting analysis of proteins present in a
crude membrane fraction derived from human urine
fractions has also been reported to show a 17 kDa
immunoreactive band which the authors suggested
might be the result of proteolytic fragments of AQP-2
w x7 . To determine if the 17 kDa band recognized by
rabbit anti-AQP-2 antiserum in membrane fractions
of rat kidney is also present in human urine samples,
immunoblotting analysis was performed on human
Fig. 10. Anti-aquaporin 2 immunoblots of human urine display a
17 kDa band that is ablated by blocking with 3% gelatin. A crude
membrane preparation was prepared by ultracentrifugation of
human urine from antidiuretic normal human volunteers and
40-mg aliquots were subjected to immunoblotting analyses identi-
cal to that described in lanes 1 and 2 of Fig. 7. Note that blocking
of immunoblotting strip with 2% BSA results in appearance of 28
 .kDa and 17 kDa bands lane 1 . In contrast, after blocking the
strips with 3% gelatin, the 28 kDa band remains while the 17
kDa band is ablated. These data are from a single representative
experiment performed a total of four times on separate urine
samples.
urinary proteins as described in Fig. 7 after blocking
nitrocellulose strips in either 2% BSA Fig. 10, lane
.  .1 or 3% gelatin Fig. 10, lane 2 . In a manner
identical to that displayed in samples of rat kidney
protein, this antiserum also identified a 17 kDa im-
munoreactive band that was absent in samples blocked
with 3% gelatin. Since crude fractions derived from
human urine contain abundant fragments of renal
epithelial cells shed from renal tubules, the presence
of fragments of nuclei of renal epithelial cell as well
as membranes provides a likely explanation for the
presence of the 17 kDa band in human urine.
4. Discussion
Considerable data demonstrate that rabbit antisera
raised to peptides containing amino acid sequences
present in the C-terminal of AQP-2 specifically iden-
tify the AQP-2 protein in immunolocalization and
w ximmunoblotting experiments 4–13 . These data show
that AQP-2 protein is expressed exclusively by ADH
responsive epithelial cells in kidney collecting duct.
These cells are most abundant in kidney inner medulla
and papilla but are also constituents of the collecting
ducts of kidney cortex and outer medulla. The pres-
ence of prominent 29 kDa and 35–45 kDa bands on
immunoblots that correspond to the predicted sizes of
nonglycosylated and glycosylated AQP-2 proteins re-
spectively together with specific prominent labeling
of the apical plasma membrane and adjacent vesicles
in ADH responsive epithelial cells in rat kidney inner
medulla and papilla has led to a general acceptance
of these antisera as being specific for the AQP-2
protein. However, multiple reports of the absence
w x18 and presence of a 17 kDa immunoreactive band
w x6,8,11,12 together with many other publications
w xwhere this region of immunoblots is not shown 7,10 ,
have raised questions as to whether this 17 kDa band
is structurally related to AQP-2 or is another distinct
protein.
These data displayed in Figs. 1–10 demonstrate
that seven separate anti-AQP-2 antisera recognized
this 17 kDa immunoreactive band on immunoblots of
membrane fractions prepared from the rat kidney. In
contrast, one antiserum displayed no reactivity to a
17 kDa band when assayed under identical condi-
tions. No significant immunoreactivity of 17 kDa
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band is present in other rat tissues such as brain,
heart, liver, lung and spleen. Moreover, the degree of
total immunoreactivity of 17 kDa band in various
tissue regions of kidney is directly proportional to the
abundance of both 29 kDa and 35–45 kDa bands. To
determine the nature of this 17 kDa band, we per-
formed experiments to distinguish whether this im-
munoreactive band is a proteolytic fragment of the
larger 29 kDa or 35–45 kDa AQP-2 protein or
another unrelated immunoreactive protein.
Our purification and limited protein sequencing
data show that the 17 kDa band is not a structurally-
related AQP-2 protein but rather a denatured histone
H2A1. Purification of the 17 kDa band took advan-
tage of the acid solubility of histone proteins while
the bulk of the other proteins present in the TX-100-
insoluble pellet remained in an insoluble protein mass.
Purified histone H2A1 coelectrophoreses with the 17
kDa band from rat inner medulla and papilla and both
bind anti-AQP-2 antisera. This spurious labeling of
purified histone H2A1 and the 17 kDa band in kidney
medulla and papilla exhibited by anti-AQP-2 antisera
can be eliminated from immunoblots containing his-
tone, rat kidney protein and human urine samples by
preincubation of blots in 3% gelatin. True crossreac-
tivity between epitopes present in histone H2A1 and
AQP-2 is demonstrated by the preabsorption of anti-
AQP-2 antiserum with histone H2A1 protein which
results in a 71"17% reduction in anti-AQP-2 bind-
ing to both the 29 kDa and 35-45 kDa bands of
AQP-2 protein as well as ablation of the 17 kDa
band.
 .Identification of the exact epitope s recognized by
anti-AQP-2 antisera is not readily apparent from
analyses of the sequence of the histone H2A1 protein.
Comparison of the published H2A1 protein sequence
to that of the AQP-2 peptide Glu-Leu-His-Ser-Pro-
Gln-Ser-Leu-Pro-Arg-Gly-Ser-Lys-Ala reveals no
identical full length matches. However, such analyses
are complicated by the fact that multiple forms of
H2A1 protein are expressed in various vertebrate
tissues and the sequence of relative few H2A1s have
w xbeen determined completely 22,23 .
At the present time, the reason why significant
immunoreactivity of 17 kDa band is present only in
kidney inner medulla and papilla but not other rat
tissues is interesting, but yet to be fully understood.
One possible reason is the presence of a specific
histone isoform H2A1 in only kidney preparations
andror a larger recovery of nuclear fractions contain-
ing histone H2A1 during subcellular fractionation
from unknown factors such as size or density of
kidney nuclei.
The elimination of anti-AQP-2 antisera binding to
denatured histone H2A1 on immunoblots by preincu-
bation with gelatin provides a possible explanation
for both the lack of labeling of nuclei in immuno-
cytochemistry sections as well as reports that do not
apparently detect significant amounts of 17 kDa pro-
tein on immunoblots using anti-AQP-2 antisera. Since
histones remain in close contact with nuclear DNA in
w x  .immunocytochemistry sections 5 , epitope s recog-
nized by anti-AQP-2 antisera may not be exposed
and binding of anti-AQP-2 antisera is prevented. In a
similar fashion, permeabilization or solubilization of
cellular proteins with nondenaturing detergents such
as Triton X-100 that preserve histone binding to
DNA also would be expected to eliminate or mini-
mize AQP-2 antisera binding to histone H2A1. In
wcontrast, solubilization of crude cellular fractions 5–
x12 or concentrated urinary protein containing cellu-
w xlar debris including nuclei 8 with the denaturing
detergent SDS when applied directly to SDS-PAGE
gels likely results in exposure of these H2A1 epitopes
on immunoblots subsequently blocked with BSA.
In conclusion, the immunoreactive 17 kDa protein
present in the kidney inner medulla and papilla is not
a component of AQP-2, and care should be exercised
in any immunoassay using many existing anti-AQP-2
antisera to prevent spurious binding to this histone
H2A1 protein expressed in kidney membranes.
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